YOU ARE HERE:
Side-effects news
page  of 19
 
Headline
Date
  Even a very low viral load may cause hardening of the arteries in patients with HIV
26.05.09
  Don't take Ginkgo biloba with efavirenz
21.05.09
  High prevalence of lipodystropy amongst patients taking HIV treatment in Senegal: d4T sole risk factor
11.05.09
  Single DNA change may identify susceptibility to tenofovir-related kidney damage
08.05.09
  HIV treatment does not increase the risk of fractures
07.05.09
  Cosmetic treatment for facial fat loss safe and effective in the long term
27.04.09
  Starting HIV therapy improves some cardiovascular markers - but not all
21.04.09
  Bone loss during HIV treatment most associated with protease inhibitors
16.04.09
  Higher rates of breast enlargement in men in South Africa on ART
14.04.09
  FDA cautions that Kaletra should not be used by patients with heart rhythm problems or underlying heart conditions
14.04.09
  Vitamin D supplementation may help with tenofovir-related bone hormone deficiency
05.04.09
  HIV treatment is not the cause of cryptogenic liver disease
27.03.09
  Body-shape changes and lipid abnormalities common in HIV-positive children and young adults
19.03.09
  Efavirenz dose reduction safe for patients with gene associated with high drug levels and side-effects
12.03.09
  Endothelial dysfunction in Italian cohort caused by HIV, not antiretrovirals, researchers conclude
09.03.09
  Poorer responses to lipid-lowering drugs in people with HIV
03.03.09
  HIV infection has similar impact on hardening of arteries as smoking, diabetes
12.02.09
  Abacavir may increase blood coagulation risk
12.02.09
  Diabetes, high blood pressure and smoking raise risk of death for all people with HIV
11.02.09
  Certain protease inhibitors and abacavir linked to heart attacks in two large cohort studies
10.02.09

page  of 19